Logo image of VINC

VINCERX PHARMA INC (VINC) Stock News

NASDAQ:VINC - Nasdaq - US92731L1061 - Common Stock

0.1523  +0.01 (+8.71%)

After market: 0.152 0 (-0.2%)

VINC Latest News and Analysis

News Image
2 days ago - Chartmill

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Curious about the stocks that are showing activity after the closing bell on Thursday?

News Image
11 days ago - Halper Sadeh LLP

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
16 days ago - Chartmill

Curious about the stocks that are showing activity after the closing bell on Thursday?

Thursday's after hours session: top gainers and losers

News Image
18 days ago - Halper Sadeh LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

News Image
18 days ago - Chartmill

Unusual volume stocks in Tuesday's session

Which stocks have an unusual volume on Tuesday?

News Image
19 days ago - Chartmill

Curious about the stocks that are showing activity after the closing bell on Monday?

Curious about the stocks that are showing activity after the closing bell on Monday?

News Image
19 days ago - Chartmill

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Top movers analysis in the middle of the day on 2024-12-30: top gainers and losers in today's session.

News Image
20 days ago - Chartmill

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.

News Image
20 days ago - Chartmill

What's going on in today's pre-market session

The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

News Image
22 days ago - Vincerx Pharma, Inc.

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

Proposed merger would add a differentiated Phase 3 TROP2 Antibody-drug Conjugate (ADC) to the combined company’s pipeline...

News Image
2 months ago - Vincerx Pharma, Inc.

Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943

Also Exploring Strategic Alternatives to Complement Fundraising Efforts...

News Image
2 months ago - Vincerx Pharma, Inc.

Vincerx Pharma Reports Third Quarter 2024 Financial Results

Continued enrollment and dose escalation in Phase 1 study of VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC); additional data...

News Image
3 months ago - Vincerx Pharma, Inc.

Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates

VIP943 demonstrates promising safety and tolerability and achieves two complete responses to date in Phase 1 dose-escalation study, reinforcing the...

News Image
5 months ago - InvestorPlace

VINC Stock Earnings: Vincerx Pharma Beats EPS for Q2 2024

VINC stock results show that Vincerx Pharma beat analyst estimates for earnings per share the second quarter of 2024.

News Image
5 months ago - Vincerx Pharma, Inc.

Vincerx Pharma Reports Second Quarter 2024 Financial Results

Vincerx continues to enroll its Phase 1 studies of antibody-drug conjugate (ADC) VIP943, with data expected by the end of Q4 2024, and small molecule...

News Image
8 months ago - InvestorPlace

VINC Stock Earnings: Vincerx Pharma Misses EPS for Q1 2024

VINC stock results show that Vincerx Pharma missed analyst estimates for earnings per share the first quarter of 2024.

News Image
8 months ago - BusinessInsider

VINC Stock Earnings: Vincerx Pharma Misses EPS for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Vincerx Pharma (NASDAQ:VINC) just reported results for the first quarter of 202...

News Image
8 months ago - Vincerx Pharma, Inc.

Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

Vincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236,...

News Image
9 months ago - Vincerx Pharma, Inc.

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants

PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced the pricing of an underwritten public offering...

News Image
9 months ago - Vincerx Pharma, Inc.

Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants

PALO ALTO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced a proposed underwritten public offering of...

News Image
9 months ago - InvestorPlace

Why Is Laser Photonics (LASE) Stock Up 130% Today?

Laser Photonics stock is rising higher on Tuesday as LASE investors celebrate a new unit order from L3Harris Technologies.

News Image
9 months ago - InvestorPlace

Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?

Vivos Therapeutics stock is up on Tuesday as VVOS investors react to the company securing full Medicare reimbursement for its OSA device.